Sunshine Biopharma, Inc·4/A

Oct 4, 11:57 AM ET

MERZOUKI ABDERRAZZAK 4/A

4/A · Sunshine Biopharma, Inc · Filed Oct 4, 2019

Insider Transaction Report

Form 4/AAmended
Period: 2016-04-22
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
  • Award

    Common Stock

    2018-04-22$0.00/sh+12,000,000$12,00012,000,000 total

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT